In another study, cell membrane vesicles from melanoma cells were combined with CpG oligonucleotides, TLR-9 agonist and DCs-targeting aptamer, enabling specific activation of immune system against cancer, together with a long-term immune memory effect (263). This evidence concerns the gene TLR9 and melanoma.